Performance was characterized by resilient demand in consumer-facing segments, specifically Life Sciences and Personal Care, which provided stability against a mixed macro environment. Life Sciences growth was driven by a fourth consecutive quarter of volume gains in pharma, particularly in injectables and tablet coatings, despite softness in nutrition due to order timing. Personal Care achieved broad-based growth through double-digit gains in biofunctional actives and share expansion in microbial pro ...